Definition

A monoclonal antibody targeting an as of yet undisclosed tumor-associated antigen (TAA), with potential antineoplastic activity. Upon administration of B013, the monoclonal antibody targets and binds to the TAA expressed on tumor cells. This may result in the death of tumor cells expressing the TAA through an as of yet not elucidated mechanism of action.